Company: INGVF
Filing Date: 2025-03-20
Form Type: 424B5
Source: 0001193125-25-058308
Chunk: 171

Company: ING GROEP NV
Filing Date: 2025-03-20
Form: 424B5
Chunk 171
---
 made to the general meeting to delegate authority to the Executive Board to resolve on the issuance of new ordinary shares or to grant rights to subscribe to new ordinary shares, both with and without pre-emptiverights for existing shareholders. The set-upand content of the currently applicable share issue authorization have been discussed with many investors, proxy advisors and other stakeholders in the context of the corporate governance review of 2016 and in the general meetings of 2016 and subsequent years; their feedback has taken into account. The current share issue authorization enables the Executive Board to resolve on the issuance of new ordinary shares (including the granting of rights to subscribe for ordinary shares, such as warrants or in connection with convertible debt instruments) for a period of 18 months, ending on October 25, 2023 (or when the authorization is renewed, whichever is earlier) subject to the following conditions and limits:

| · |     | No more than 40% of the issued share capital in connection with a rights issue, being a share offering to all shareholders in proportion to their existing 
 holdings of ordinary shares. However, the                                                                                                                  |

-73-

| Executive Board and Supervisory Board may exclude certain shareholders from such a share offering for practical or legal reasons; plus |

| · |     | No more than 10 percent of the issued share capital, with or without pre-emptive rights of existing shareholders. |

Specific approval by the general meeting is required for any share issuance exceeding these limits. The purpose of this share issue authorization is to delegate the power to issue new ordinary shares to the Executive Board. Accordingly, the Executive Board is authorized to resolve on the issuance of new ordinary shares without first having to obtain the consent of the general meeting, which in The Netherlands is subject to a statutory convocation period of at least 42 days. This authorization gives ING Group flexibility in managing its capital resources, including regulatory capital, while taking into account shareholders’ interests to prevent dilution of their shares. It particularly enables ING Group to respond promptly to developments in the financial markets, should circumstances so require. This authorization may be used for any purpose, including but not limited to strengthening capital, financing, mergers or acquisitions. However, the authorization to issue ordinary shares by way of rights issue cannot be used for mergers or acquisitions on a stock-for-stockbasis as this is incompatible with the concept of pre-emptiverights for existing shareholders. In line with market practice, ING Group currently intends to include the following categories of shareholders in such a rights issue